help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on December 30, 2003, doi:10.1164/rccm.200307-1042OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200307-1042OCv1
169/6/726    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Park, J.-W.
Right arrow Articles by Gelfand, E. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Park, J.-W.
Right arrow Articles by Gelfand, E. W.
American Journal of Respiratory and Critical Care Medicine Vol 169. pp. 726-732, (2004)
© 2004 American Thoracic Society


Original Article

Complement Activation Is Critical to Airway Hyperresponsiveness after Acute Ozone Exposure

Jung-Won Park, Christian Taube, Anthony Joetham, Katsuyuki Takeda, Taku Kodama, Azzeddine Dakhama, Glen McConville, Corrie B. Allen, Georgia Sfyroera, Lenny D. Shultz, John D. Lambris, Patricia C. Giclas, V. Michael Holers and Erwin W. Gelfand

Division of Cell Biology, Department of Pediatrics, National Jewish Medical and Research Center; Department of Medicine, University of Colorado Health Sciences Center, Denver, Colorado; Protein Chemistry Laboratory, Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; and The Jackson Laboratory, Bar Harbor, Maine

Correspondence and requests for reprints should be addressed to Erwin W. Gelfand, M.D., National Jewish Medical and Research Center, 1400 Jackson Street, Denver, CO 80206. E-mail: gelfande{at}njc.org

Ozone (O3) can induce airway hyperresponsiveness (AHR) and neutrophilic inflammation. We evaluated the role of complement in development of AHR and inflammation after acute O3 exposure in mice. Mice were exposed to O3 at 2 ppm for 3 hours, and airway responsiveness to methacholine was measured 8 hours after O3 exposure. Complement was depleted or inhibited by intraperitoneal injection of cobra venom factor (CVF) or complement receptor–related gene y (Crry)–Ig, a potent C3 convertase inhibitor; neutrophils were depleted using an antineutrophil monoclonal antibody. CVF attenuated the development of AHR by O3. Administration of Crry–Ig also prevented the development of AHR. Bronchoalveolar lavage (BAL) fluid neutrophilia after O3 exposure was significantly decreased by administration of either CVF or Crry–Ig. Increased BAL fluid total protein after O3 exposure was lowered by depletion or inhibition of complement. In contrast to the effects of complement inhibition or depletion, depletion of BAL neutrophil counts by more than 90% with the monoclonal antibody did not affect the development of AHR after O3 exposure. These data indicated that activation of the complement system follows acute O3 exposure and is important to the development of AHR and airway neutrophilia. However, this neutrophil response does not appear necessary for the development of AHR.

Key Words: ozone • complement activation • airway hyperresponsiveness




This article has been cited by other articles:


Home page
Am. J. Respir. Cell Mol. Bio.Home page
K. C. Verhein, D. B. Jacoby, and A. D. Fryer
IL-1 Receptors Mediate Persistent, but Not Acute, Airway Hyperreactivity to Ozone in Guinea Pigs
Am. J. Respir. Cell Mol. Biol., December 1, 2008; 39(6): 730 - 738.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
K. L. Oslund, D. M. Hyde, L. F. Putney, M. F. Alfaro, W. F. Walby, N. K. Tyler, and E. S. Schelegle
Activation of Neurokinin-1 Receptors during Ozone Inhalation Contributes to Epithelial Injury and Repair
Am. J. Respir. Cell Mol. Biol., September 1, 2008; 39(3): 279 - 288.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
J. W. Hollingsworth, S. R. Kleeberger, and W. M. Foster
Ozone and Pulmonary Innate Immunity
Proceedings of the ATS, July 1, 2007; 4(3): 240 - 246.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
M. Wills-Karp
Complement Activation Pathways: A Bridge between Innate and Adaptive Immune Responses in Asthma
Proceedings of the ATS, July 1, 2007; 4(3): 247 - 251.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Taube, J. M. Thurman, K. Takeda, A. Joetham, N. Miyahara, M. C. Carroll, A. Dakhama, P. C. Giclas, V. M. Holers, and E. W. Gelfand
Factor B of the alternative complement pathway regulates development of airway hyperresponsiveness and inflammation
PNAS, May 23, 2006; 103(21): 8084 - 8089.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
B. Nemery, W. W. Yew, R. Albert, C. Brun-Buisson, W. MacNee, F. J. Martinez, D. C. Angus, and E. Abraham
Tuberculosis, Nontuberculous Lung Infection, Pleural Disorders, Pulmonary Function, Respiratory Muscles, Occupational Lung Disease, Pulmonary Infections, and Social Issues in AJRCCM in 2004
Am. J. Respir. Crit. Care Med., March 15, 2005; 171(6): 554 - 562.
[Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. K. Pulfer, C. Taube, E. Gelfand, and R. C. Murphy
Ozone Exposure in Vivo and Formation of Biologically Active Oxysterols in the Lung
J. Pharmacol. Exp. Ther., January 1, 2005; 312(1): 256 - 264.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
R. A. Johnston, J. P. Mizgerd, and S. A. Shore
CXCR2 is essential for maximal neutrophil recruitment and methacholine responsiveness after ozone exposure
Am J Physiol Lung Cell Mol Physiol, January 1, 2005; 288(1): L61 - L67.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
C. Gerard
Flies, Mice, and Surprises in Dissecting Environmental Lung Injury
Am. J. Respir. Crit. Care Med., July 15, 2004; 170(2): 106 - 107.
[Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
J.-W. Park, C. Taube, C. Swasey, T. Kodama, A. Joetham, A. Balhorn, K. Takeda, N. Miyahara, C. B. Allen, A. Dakhama, et al.
Interleukin-1 Receptor Antagonist Attenuates Airway Hyperresponsiveness Following Exposure to Ozone
Am. J. Respir. Cell Mol. Biol., June 1, 2004; 30(6): 830 - 836.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2004 American Thoracic Society
  ATS State of the Art 2009